GL1X · GenesisL1 explorer

MolNFT v1 · #147355 · protein

Crystal structure of human respiratory syncytial virus fusion glycoprotein inhibitor escape variant L141W stabilized in the prefusion state

6EAE · Fusion glycoprotein F0: “Crystal structure of human respiratory syncytial virus fusion glycoprotein inhibitor escape variant L141W…”. X-ray diffraction, 1 ligand (SO4), 2 pockets (best druggability 0.42). MolNFT v1 #147355 on…

PDB
6EAE
Type
protein
Length
451 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fusion glycoprotein F0
UniProt
W8RJF9
Ligands
SO4
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
FFusion glycoprotein F0protein45130% helix, 33% strandW8RJF9

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 5 copies · chains F
  • NHE · 2-[N-cyclohexylamino]ethane sulfonic acid · additive · 2 copies · chains F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11320.420.7523empty
2640.360.7814empty

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 6EAE · Crystal structure of human respiratory syncytial virus fusion glycoprotein inhibitor… · the same entry in another collection · chain F against F, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.